Trecator (Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.)
Welcome to the PulseAid listing for the Trecator drug offered from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.. This Antimycobacterial [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
NON-PROPRIETARY NAME: | ethionamide |
SUBSTANCE NAME: | ETHIONAMIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Antimycobacterial [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET, FILM COATED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2004-11-08 |
END MARKETING DATE: | 0000-00-00 |
Trecator HUMAN PRESCRIPTION DRUG Details:
Item Description | Trecator from Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
LABELER NAME: | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 250(mg/1) |
START MARKETING DATE: | 2004-11-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0008-4117_b4a80867-83e7-4ce0-8023-4f02c6765b90 |
PRODUCT NDC: | 0008-4117 |
APPLICATION NUMBER: | NDA013026 |
Other ETHIONAMIDE Pharmaceutical Manufacturers / Labelers: